Fred Eshelman
Vorsitzender bei ARAVIVE, INC.
Vermögen: 3 Mio $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jay C. Strum | M | - |
Incyclix Bio LLC
Incyclix Bio LLC Pharmaceuticals: MajorHealth Technology Incyclix Bio, Inc., formerly known as Arc Therapeutics, is a pharmaceutical company that focuses on developing small molecule inhibitors of cyclin-dependent kinases (CDKs) to treat advanced and resistant cancers. The company is based in Durham, NC. The company's team has unique insights into the biology and structure of CDKs, which will facilitate the rapid discovery and development of a novel, potent, and selective Cdk2 inhibitor. Incyclix Bio was founded by industry experts with robust drug design, discovery, and development experience, including Patrick Roberts, John Bisi, Fredric N. Eshelman, and Jay C. Strum. Patrick Roberts has been the CEO since incorporation. | 15 Jahre |
Gail McIntyre | M | 61 | 11 Jahre | |
John Paulson | M | 68 | 7 Jahre | |
Michael Rowe | M | 62 | 6 Jahre | |
Robert Rosewell Chai-Onn | M | 52 |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | 7 Jahre |
Edward C. Burgard | M | - |
Dignify Therapeutics LLC
Dignify Therapeutics LLC Pharmaceuticals: MajorHealth Technology Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC. | 11 Jahre |
Jack Bailey | M | 59 | 4 Jahre | |
Brainard Hartman | M | 60 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 23 Jahre |
Patrick Roberts | M | - |
Incyclix Bio LLC
Incyclix Bio LLC Pharmaceuticals: MajorHealth Technology Incyclix Bio, Inc., formerly known as Arc Therapeutics, is a pharmaceutical company that focuses on developing small molecule inhibitors of cyclin-dependent kinases (CDKs) to treat advanced and resistant cancers. The company is based in Durham, NC. The company's team has unique insights into the biology and structure of CDKs, which will facilitate the rapid discovery and development of a novel, potent, and selective Cdk2 inhibitor. Incyclix Bio was founded by industry experts with robust drug design, discovery, and development experience, including Patrick Roberts, John Bisi, Fredric N. Eshelman, and Jay C. Strum. Patrick Roberts has been the CEO since incorporation. | 4 Jahre |
Garry Nicholson | M | 69 | 6 Jahre | |
Karl B. Thor | M | - |
Dignify Therapeutics LLC
Dignify Therapeutics LLC Pharmaceuticals: MajorHealth Technology Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC. | 11 Jahre |
Thomas F. Tedder | M | - |
Cellective BioTherapy, Inc.
Cellective BioTherapy, Inc. Pharmaceuticals: MajorHealth Technology Cellective BioTherapy, Inc. engages in the research and development of novel cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity, and immunodeficiency. Its proprietary pipeline and technology platform focuses on the unique aspects of B cell biology that are involved in regulating a variety of autoimmune diseases and inflammatory immune responses. The company was founded by Thomas F. Tedder in 2015 and is headquartered in Durham, NC. | 9 Jahre |
John Gandolfo | M | 63 | 7 Jahre | |
Cynthia Flowers | F | 64 | 6 Jahre | |
Lesley Marson | M | - |
Dignify Therapeutics LLC
Dignify Therapeutics LLC Pharmaceuticals: MajorHealth Technology Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC. | 11 Jahre |
Andrew von Eschenbach | M | 82 |
Innocrin Pharmaceuticals Holdings LLC
Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC.
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | - |
Charles Mather | M | 64 | 6 Jahre | |
Daniel J. Ricca | M | - |
Dignify Therapeutics LLC
Dignify Therapeutics LLC Pharmaceuticals: MajorHealth Technology Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC. | 11 Jahre |
Lee Kramm | M | - | 7 Jahre | |
Robert J. Bonczek | - | - |
Cellective BioTherapy, Inc.
Cellective BioTherapy, Inc. Pharmaceuticals: MajorHealth Technology Cellective BioTherapy, Inc. engages in the research and development of novel cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity, and immunodeficiency. Its proprietary pipeline and technology platform focuses on the unique aspects of B cell biology that are involved in regulating a variety of autoimmune diseases and inflammatory immune responses. The company was founded by Thomas F. Tedder in 2015 and is headquartered in Durham, NC. | - |
Sarah Kavanagh | F | 67 | 8 Jahre | |
William C. Roberts | M | 54 | 3 Jahre | |
Amy Wechsler | M | 54 | 8 Jahre | |
Arthur J. Shannon | M | - | 7 Jahre | |
Rick S. Kent | M | 74 |
Innocrin Pharmaceuticals Holdings LLC
Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC.
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | - |
Joyce McKenzie | F | - |
Aero MD
| - |
Terry Murdock | M | 64 | 7 Jahre | |
Douglas Reed | M | 70 |
Innocrin Pharmaceuticals Holdings LLC
Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC.
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | 10 Jahre |
Rachel Jacobson | F | 50 | 2 Jahre | |
Glenn Muir | M | 65 | 9 Jahre | |
John Bisi | M | - |
Incyclix Bio LLC
Incyclix Bio LLC Pharmaceuticals: MajorHealth Technology Incyclix Bio, Inc., formerly known as Arc Therapeutics, is a pharmaceutical company that focuses on developing small molecule inhibitors of cyclin-dependent kinases (CDKs) to treat advanced and resistant cancers. The company is based in Durham, NC. The company's team has unique insights into the biology and structure of CDKs, which will facilitate the rapid discovery and development of a novel, potent, and selective Cdk2 inhibitor. Incyclix Bio was founded by industry experts with robust drug design, discovery, and development experience, including Patrick Roberts, John Bisi, Fredric N. Eshelman, and Jay C. Strum. Patrick Roberts has been the CEO since incorporation. | 4 Jahre |
S. Torres | M | 61 |
Innocrin Pharmaceuticals Holdings LLC
Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC.
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | - |
Robert J. Schotzinger | M | 63 |
Innocrin Pharmaceuticals Holdings LLC
Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC.
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | - |
Christina Ackermann | F | 59 | 8 Jahre | |
Ann Goodnight | F | - |
University of North Carolina System
| - |
Kristy Borawski | M | - |
Dignify Therapeutics LLC
Dignify Therapeutics LLC Pharmaceuticals: MajorHealth Technology Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC. | - |
Bradley Kropp | M | - |
Dignify Therapeutics LLC
Dignify Therapeutics LLC Pharmaceuticals: MajorHealth Technology Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC. | - |
Gary Mawe | M | - |
Dignify Therapeutics LLC
Dignify Therapeutics LLC Pharmaceuticals: MajorHealth Technology Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC. | - |
Mark Avagliano | M | 48 | 5 Jahre | |
Melissa Waller | F | 54 |
University of North Carolina System
| - |
William L. Roper | M | 75 |
University of North Carolina System
| 5 Jahre |
Aldona Wos | M | - |
University of North Carolina System
| 12 Jahre |
John Umstead | M | - | 6 Jahre | |
James R. Renna | M | - |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | - |
Eric Epstein | M | - |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | - |
Danny R. Frank | M | 67 |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | - |
Howard Schiller | M | 61 |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | - |
Marek Ciszewski | M | - | - | |
Louis Yu | M | 73 | 8 Jahre | |
Matthias C. Kurth | M | 68 |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | - |
Brent D. Barringer | M | 65 |
University of North Carolina System
| - |
Theodore J. Theophilos | M | 70 |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | - |
Champion Mitchell | M | 77 |
University of North Carolina System
| - |
Norbert Lowe | M | - | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Ernest Mario | M | 85 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 27 Jahre |
Glenn Sblendorio | M | 68 | 16 Jahre | |
Stuart O. Bondurant | M | 94 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | - |
June Almenoff | M | 67 | 4 Jahre | |
Jay Shepard | M | 65 | 7 Jahre | |
Robert Alexander Ingram | M | 81 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 14 Jahre |
Jennifer Moses | F | 49 | - | |
Robert L. Rosiello | M | 66 | 1 Jahre | |
Rekha Hemrajani | F | 54 | - | |
Raymond Tabibiazar | M | 53 | - | |
J. Pearson | M | 64 | 8 Jahre | |
Joseph Papa | M | 68 | 6 Jahre | |
Christy Shaffer | M | 66 | 6 Jahre | |
Fred Davenport | M | 72 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 10 Jahre |
Paul S. Covington | M | 68 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 17 Jahre |
Rudy Howard | M | 67 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 8 Jahre |
Srini Akkaraju Akkaraju | M | 56 | - | |
Willie Deese | M | 68 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 26 Jahre |
Vaughn D. Bryson | M | 85 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | - |
Daniel G. Darazsdi | M | 63 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 7 Jahre |
Eric Abramson | M | - | - | |
Katharine Stevenson | F | 61 | 6 Jahre | |
Robert Hale | M | 39 | 6 Jahre | |
Neil McCullough | M | - |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | - |
Raymond Hill | M | - |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | - |
Thomas Ross | M | 73 | 8 Jahre | |
Neera D. Ravindran | M | - | - | |
Russel Robertson | M | 76 | 8 Jahre | |
Peter Wilkinson | M | 53 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | 9 Jahre |
Bill O'Connor | M | 64 | 12 Jahre | |
Scott Andrew Hirsch | M | 47 | 5 Jahre | |
Ralph Snyderman | M | 84 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | - |
Norma Provencio | F | 67 | 6 Jahre | |
Melvin Spigelman | M | 75 | 13 Jahre | |
Stephen Fraidin | M | - | - | |
Ron Farmer | M | 73 | 5 Jahre | |
Argeris Karabelas | M | 71 | 7 Jahre | |
Marshall H. Woodworth | M | 66 | 3 Jahre | |
Anders O. Lönner | M | 79 | 2 Jahre | |
Robert G. Savage | M | 70 | 13 Jahre | |
Sam Eldessouky | M | 51 | 6 Jahre | |
Terry R. Magnuson | M | 73 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | - |
Robert Hugin | M | 69 | 15 Jahre | |
William W. Crouse | M | 80 | 15 Jahre | |
Richard de Schutter | M | 83 | 6 Jahre | |
James Hanson | M | 52 | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 78 | 78,00% |
Kanada | 24 | 24,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Fred Eshelman
- Persönliches Netzwerk